BillionToOne, Inc.

Equities

BLLN

US0901681058

Market Closed - Nasdaq Other stock markets 02:30:00 17/01/2026 am IST			5-day change	1st Jan Change
88.73 ^USD	-6.32%		+3.25%	+8.42%

15/01	BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite	MT
15/01	BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare	CI

Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025

Published on 12/13/2025 at 02:23 am IST - Modified on 12/13/2025 at 03:35 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

BillionToOne Third Quarter 2025 Earnings Call. [Operator Instructions]. Please be advised that today's call is being recorded.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about BillionToOne, Inc.

15/01	BillionToOne to Integrate Testing Portfolio With Epic's Diagnostics Suite	MT
15/01	BillionToOne, Inc. Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare	CI
15/01	Billiontoone announces collaboration with Epic to expand prenatal and oncology testing across healthcare	RE
12/01	BillionToOne Reaffirms 2025 Revenue Guidance, Issues 2026 Guidance	MT
12/01	(BLLN) BillionToOne Expects 2025 Revenue Range $293M - $299M, vs. FactSet Est of $296.2M	MT
12/01	(BLLN) BillionToOne Expects 2026 Total Revenue Range $415M to $430M, vs. FactSet Est of $402.3M	MT
12/01	Billiontoone provides guidance for 2026	RE
12/01	Billiontoone, Inc. Provides Earnings Guidance for 2026	CI
07/01	BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East	CI
06/01	Billiontoone announces selection of Northstar Select® as the new liquid biopsy test	RE
06/01	Guggenheim Initiates BillionToOne at Buy With $120 Price Target	MT
22/12	BillionToOne, Inc.(NasdaqGS:BLLN) added to S&P TMI Index	CI
13/12	BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025
10/12	BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours	MT
10/12	(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M - $299M, vs. FactSet Est of $288.6M	MT
10/12	Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14	MT
10/12	(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M - $90.0M	MT
10/12	Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M	MT
10/12	Billiontoone, Inc. Appoints Anthony Pagano to Its Board of Directors, Effective January 1, 2026	CI
10/12	BillionToOne, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/12	Billiontoone, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year 2025	CI
01/12	BillionToOne Shares Fall After Jefferies Initiates Coverage at Hold	MT
01/12	Jefferies Initiates BillionToOne at Hold With $117 Price Target	MT
01/12	Stifel Initiates BillionToOne at Buy With $145 Price Target	MT
01/12	Piper Sandler Initiates BillionToOne at Overweight With $150 Price Target	MT